Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling by Carbone, C et al.
OPEN
ORIGINAL ARTICLE
Adipocytes sustain pancreatic cancer progression through a
non-canonical WNT paracrine network inducing ROR2
nuclear shuttling
C Carbone1,10, G Piro1,2,10, N Gaianigo1, F Ligorio1, R Santoro1, V Merz3, F Simionato3, C Zecchetto3, G Falco4, G Conti5, PT Kamga6,
M Krampera6, F Di Nicolantonio7,8, L De Franceschi9, A Scarpa10, G Tortora2,3 and D Melisi1,3
BACKGROUND: Solid epidemiological evidences connect obesity with incidence, stage and survival in pancreatic cancer. However,
the underlying mechanistic basis linking adipocytes to pancreatic cancer progression remain largely elusive. We hypothesized that
factors secreted by adipocytes could be responsible for epithelial-to-mesenchymal transition (EMT) induction and, in turn, a more
aggressive phenotype in models of pancreatic preneoplastic lesions.
METHODS: We studied the role of factors secreted by two adipogenic model systems from primary human bone marrow stromal
cells (hBMSCs) in an in vitro experimental cell transformation model system of human pancreatic ductal epithelial (HPDE) cell stably
expressing activated KRAS (HPDE/KRAS),
RESULTS: We measured a significant induction of EMT and aggressiveness in HPDE and HPDE/KRAS cell lines when cultured with
medium conditioned by fully differentiated adipocytes (ADIPOCM) if compared with the same cells cultured with medium
conditioned by hBMSC (hBMSCCM) from two different healthy donors. Several genes coding for soluble modulators of the non-
canonical WNT signaling pathway, including FRZB, SFRP2, RSPO1, WNT5A and 5B were significantly overexpressed in fully
differentiated adipocytes than in their respective in hBMSC. ADIPOCM induced the overexpression and the nuclear translocation of
the Frizzled family member receptor tyrosine kinase-like orphan receptor (Ror) 2 in HPDE and HPDE/KRAS cells. Vantictumab, an
anti-Frizzled monoclonal antibody, reduced ROR2 nuclear translocation and in turn the EMT and aggressiveness in HPDE and HPDE/
KRAS cells.
CONCLUSIONS: We demonstrated that adipocytes could induce EMT and aggressiveness in models of pancreatic preneoplastic
lesions by orchestrating a complex paracrine signaling of soluble modulators of the non-canonical WNT signaling pathway that
determine, in turn, the activation and nuclear translocation of ROR2. This signaling pathway could represent a novel target for
pancreatic cancer chemoprevention. Most importantly, these factors could serve as novel biomarkers to select a risk population
among obese subjects for screening and, thus, early diagnosis of pancreatic cancer.
International Journal of Obesity (2018) 42, 334–343; doi:10.1038/ijo.2017.285
INTRODUCTION
Cancer and obesity are the two major epidemics of the 21th
century.1 Pancreatic cancer is the fourth leading cause of cancer-
related mortality among adults in the developed countries.2 The
poor prognosis for patients with pancreatic cancer could be
mainly attributed to its aggressive course, the limited efficacy of
available systemic treatments, and, in particular, to the invariable
metastatic behavior demonstrated along the progression of the
disease.3 Thus, the identification of the earliest molecular events
responsible for the metastatic dissemination of pancreatic cancer
remains critical for early diagnosis, prevention and treatment
interventions.4–6 Solid evidences supporting the model that
metastasis is an early event in pancreatic carcinogenesis have
been provided by using a genetically engineered murine model of
pancreatic cancer in which the pancreatic epithelial cells could be
tracked during tumor progression through the expression of
yellow fluorescent protein allele into the KRas plus p53 or p16
mutant background. In this model, even low-grade PanINs showed
evidence of cells that have crossed the basement membrane,
migrated from the glandular epithelium into the surrounding
tissue and circulatory system, and seeded the liver before
pancreatic cancer formation. This behavior was associated with
an early epithelial-to-mesenchymal transition (EMT) genetic
program in the premalignant lesions.7
Several epidemiological studies demonstrated positive associa-
tions between the prevalence of obesity as judged by increased
body mass index, cancer incidence,8 poorer treatment outcome,
worsened prognosis and increased cancer-related mortality.9
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Pancreatic cancer obeys this rule, as several studies reported
elevated risks of developing this tumor in obese individuals
compared with individuals with a normal weight.10,11 In particular,
a recent prospective cohort study demonstrated that higher
prediagnostic body mass index was associated with a significantly
decreased survival among patients with pancreatic cancer. This
association was stronger for body mass index measured a greater
number of years before cancer diagnosis, suggesting that chronic
exposure to the consequences of obesity may be important in
affecting patient survival. More interestingly, this study prospec-
tively demonstrated a statistically significant association between
prediagnostic body mass index and cancer stage, with more obese
patients presenting with metastatic disease than patients with
healthy weight.12
Although the epidemiological evidence connecting obesity with
cancer incidence is strong, the underlying mechanistic basis
linking obesity per se to tumor-initiating events remains largely
elusive.13,14 Three main mechanistic connections have been
proposed for this association, including the antiapoptotic effects
of obesity-associated hyperinsulinemia, the enhanced aromatiza-
tion of sex steroids in adipose tissue, and the elaboration of
paracrine and endocrine factors, or adipokines, which promote
either tumorigenesis or angiogenesis directly from adipocytes and
stromal cells within fat pads.15,16 However, a comprehensive
analysis aimed to directly identify the actual adipokines respon-
sible for the paracrine molecular networks linking obesity and
cancer progression has not been performed before.
In this present study, we hypothesized that factors secreted by
adipocytes could be responsible for EMT induction and, in turn, a
more aggressive phenotype in models of pancreatic preneoplastic
lesions, representing the molecular mechanisms linking obesity
with pancreatic cancer progression.
MATERIALS AND METHODS
Cell lines and reagents
Human papillomavirus type 16 early gene 6 and 7-immortalized human
pancreatic ductal epithelial (HPDE) non-tumorigenic cells stably expressing
activated KRAS (HPDE/KRAS) have been previously described in Carbone
et al.17 The HPDE were routinely cultured in keratinocyte serum-free
medium supplemented by epidermal growth factor and bovine pituitary
extract (Life Technologies, Inc., Grand Island, NY, USA). Cell lines used in
this study were authenticated using DNA fingerprinting at the genomic
core facility at Wayne State University (2009) and tested for mycoplasma
contamination. Vantictumab (OMP-18R5) was purchased by OncoMed
Pharmaceuticals, (Redwood City, CA, USA) and was used at 1 μg ml–1.
Isolation and adipogenic differentiation of hBMSCs
hBMSCs were isolated and described as in Di Trapani et al.18 Briefly, human
bone marrow stromal cells (hBMSCs) were isolated from bone marrow
aspirates of healthy donors (informed consent, approved by Ethical
Committee of Azienda Ospedaliera Universitaria Integrata Verona; N. 1828,
12 May 2010- “Institution of cell and tissue collection for biomedical
research in Onco-Hematology”). Bone marrow aspirates were cultured in
225-cm2 flasks at 5 × 105 nucleated cells cm–2 concentration in alpha-
minimal essential medium, 10% heat-inactivated fetal bovine serum,
100 U ml–1 penicillin and 100 μg ml–1 streptomycin (all from Gibco,
ThermoFisher Scientific, Waltham, MA, USA). After 72 h, nonadherent cells
were removed and the medium was replaced twice a week. Published
protocol was followed to induce adipogenic differentiation of hBMSCs.19
hBMSCs were cultured at a density of 5000–6000 cells cm–2. After reaching
confluence, hBMSCs were cultured for 1 more week and induced in
adipogenic medium containing 0.5 mM isobutyl-methylxanthine (Sigma-
Aldrich), 1 μM dexamethasone (Sigma-Aldrich, Missouri, MO, USA), 10 μM
insulin (Roche, Basel, Switzerland), 100 μM indomethacin (Sigma-Aldrich)
for 3 days and maintained in medium with 10 μM insulin for 1 day. The
treatment was repeated four times, after which the cells were washed
three times with phosphate-buffered saline and maintained in Dulbecco's
modified Eagle's medium without fetal bovine serum for 4 days. The
conditional medium was collected, centrifuged.
Isolation of adipocytes from healthy donor
Subcutaneous white adipose tissue was harvested from a healthy, 40-year-
old subject with a body mass index of 23.8 kg m–2, and without diabetes
and other metabolic or cardiac disorders, by a protocol optimized by
Rigotti and colleagues.20 Lipoaspirate purification was obtained by the use
of MACS adipose tissue dissociation kit following the manufacturer's
instructions. Cellular suspension was filtered and placed in culture in
Dulbecco's modified Eagle's medium added with 1% penicillin–streptomi-
cin mixture (1:1 v/v), 10% of fetal bovine serum, 0.3% of amphotericin B
and incubated for 48 h at 37 °C and 5% of CO2.
Oil red O staining
Cells were washed three times with phosphate-buffered saline and then
fixed for 2 min with 3.7% formaldehyde. Oil red O (0.5% in isopropanol)
was diluted with water (3:2) filtered through a 0.45 μm filter and incubated
with the fixed cells for 1 h at room temperature. Cells were washed with
water and the stained fat droplets in the cells were visualized by light
microscopy and photographed.
Cell proliferation assay and western blotting
On day 0, 1.0 × 103 cells per well were seeded in 96-well plates. At the
indicated hours, sulforhodamine B (Sigma, St Louis, MO, USA) assay was
used to obtain relative estimates of viable cell number as previously
described in Piro et al.21 Western blot analyses were carried out as
described previously in Melisi et al.22 Briefly, cell lines were washed twice
with cold phosphate-buffered saline and lysed at 4 °C into RIPA buffer
(50 mM Tris–HCl, pH 8, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium
deoxycholate and 0.1% sodium dodecyl sulfate) plus protease inhibitor mix
(Sigma-Aldrich). Each lysate was separated by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis and probed with antibodies against
E-cadherin, β-catenin (Abcam, Cambridge, UK), receptor tyrosine kinase-
like orphan receptor 2 (ROR2), Histone H3, glycogen synthase kinase 3α/β
(GSK3α/β) and p-GSK3β-(S9) (Cell Signaling Technology, Boston, MA, USA),
vimentin (Dako, Glostrup, Denmark), glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) and γ-tubulin (Santa Cruz Biotechnology, Santa Cruz,
CA, USA). Immunoreactive proteins were detected using an enhanced-
chemiluminescence reagent (Millipore, Billerica, MA, USA) according to the
manufacturer’s instructions. Images were captured by LAS4000 Digital
Image Scanning System (GE Healthcare, Little Chalfont, UK).
Reverse transcription-PCR and real-time PCR
RNA was isolated by Trizol reagent as manufacturer’s instructions
(Invitrogen, Carlsbad, CA, USA). Reverse transcription-PCR assay was
performed accordingly with the High capacity cDNA reverse transcription
kit (Applied Biosystems, Foster City, CA, USA) as previously described in
Piro et al.23 The mRNA expression of CDH1, Vimentin, Leptin, ADIPOQ,
WNT5A, WNT5B, FRZB, ZEB1, SFRP2, DKK1, DKK2 and DKK3 was quantified
by using a SYBR green based real-time PCR analysis and the ABI Prism 7900
HT Sequence Detection System (Applied Biosystems). Each gene was
tested in each cell line in four replicates and three independent
experiments were performed. To quantify the relative changes in gene
expression, the 2-ΔΔCT method was used and reactions were normalized to
endogenous control gene β-actin expression levels.
Immunofluorescence
Immunofluorescence analyses were carried out as described previously in
Carbone et al.24,25 Briefly, HPDE cell lines were cultured for 24 h on cover
slips in a 24-multi-well plate. The cells were harvested and the medium
completely replaced with hBMSCCM, ADIPOCM with or without vantictu-
mab. After 24 h, cells were fixed with 2.5% formalin and permeabilized
with 0.1% Triton for 10 min at 4 °C. The cells were then incubated with the
primary antibody specific for ROR2 (Abcam) or frizzled class receptor (FZD)
for 1 h at room temperature and with fluorophore (FITC) or AlexaFluor546-
conjugated as secondary antibody (Invitrogen). Nuclei were stained with
To-Pro-3 (Invitrogen). Cover slips were mounted with pro-long antifade
mountant (Invitrogen). The images were obtained with a confocal
microscopy (LMS510, Zeiss, Oberkochen, Germany).
Wound-healing and transwell invasion assay
Wound-healing assay was performed as previously described in Carbone
et al.17 and Dalla Pozza et al.26 Briefly, HPDE in vitro cell transformation
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model systems were seeded at 70% of confluence in 100 mm cell culture
dishes. After 24 h, medium was completely replaced with hBMSCCM or
ADIPOCM. After 48 h, a straight scratch was made using a pipette tip to
simulate a wound. The cells were washed gently with cold PBS (PBS1X) and
rinsed with hBMSCCM or ADIPOCM. Photographs of at least five different
points were taken immediately and after 24 h of culture. In vitro invasion
assay were performed using 24-well transwell unit with polycarbonate
filters (Corning Costar, Cambridge, MA, USA). HPDE were suspended at
density of 5 × 105/ml in culture medium and then placed in the upper part
of transwell. Meanwhile, conditional medium from hBMSC and adipocyte
cells with or without vantictumab (1 μg ml–1) were added at the lower
wells of the chambers. Cells were incubated for 24 h, fixed with ethanol
and stained with 0.05% Crystal violet for 30 min. Cells in the upper
chamber were removed with cotton swab. Cells that invaded through the
Matrigel (MatrigelTM Basement Membrane Matrix, BD Biosciences, Franklin
Lakes, NK, USA) to the underside of the filters were counted and picture
taken under a Leica DMIL-Led microscope equipped with a Leica EC3
camera (Leica, Wetzlar, Germany). Three invasion chambers were used for
treated and untreated group. The values obtained were calculated by
averaging the total number of the cells from three filters. All experiments
were performed in triplicate.
Gene expression microarray and pathway analysis
Differences in gene expression between cell lines were examined using
Illumina Human 44k gene chips (Illumina, Milan, Italy). Briefly, synthesis of
complementary DNA and biotinylated complementary RNA was performed
using the IlluminaTotalPrep RNA Amplification Kit (Ambion, ThermoFisher
Scientific, Waltham, MA, USA), according to the manufacturer’s protocol
using 500 ng of total RNA. Hybridization of complementary RNAs (750 ng)
was carried out using Illumina Human 48 k gene chips (Human HT-12 V4
BeadChip). Array washing was performed using Illumina High Temp Wash
Buffer for 10’ at 55 °C, followed by staining using streptavidin-Cy3 dyes
(Amersham Biosciences, Buckinghamshire, UK). Probe intensity data were
Figure 1. Adipocytes secreted factors induce EMT and aggressiveness in in vitro models of pancreatic preneoplastic lesions. (a) Isolation and
adipogenic differentiation of hBMSCs. The morphology of adherent hBMSCs and adipogenic differentiation. The accumulation of cytoplasmic
triglycerides was detected by Oil Red O staining and visualized under a microscope. (b) Quantitative real-time PCR analysis of leptin (Lep) and
adiponectin (ADIPOQ) along adipogenic differentiation. The values represent the fold change in RNA expression between the gene of interest
and b-actin. (c) Western blot analysis of EMTmarker vimentin in HPDE models cultured with conditional medium (CM) from hBMSC (hBMSCCM)
and adipocytes (ADIPOCM). γ-Tubulin was used as loading control. (d) Cell proliferation assay of HPDE and HPDE/KRAS cell lines cultured with
the conditional medium from hMBSC and adipocytes. The mean values and 95% confidence interval (CI) from three independent experiments
done in quadruplicate are shown. (e) Levels of cell migration in HPDE and HPDE/KRAS cell lines co-cultured with hBMSC and adipocytes. The
mean values and 95% CI from three independent experiments done in quadruplicate are shown. ***Po0.001 by two-tailed unpaired
Student’s t-tests. Photographs of the wound area were taken by using phase-contrast microscopy immediately at indicated time point after
the incision. All these experiments were performed by using hBMSC isolated from the healthy donor 1 (#1) and its relative adipocytes.
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Figure 2. Adipocytes sustain pancreatic preneoplastic lesions aggressiveness through a WNT paracrine network. (a) Interaction network
derived from secreted genes upregulated in adipocytes versus the hBMSC cells from two healthy donors. Each interaction is supported by at
least one literature reference identified in the Ingenuity Pathway Knowledge Base, with solid lines representing direct interactions and dashed
lines representing indirect interactions. In the heat map shown in this figure, the logarithms of the gene expression levels are shown in colors
(green=decreased expression, red= increased expression). (b) Quantitative real-time PCR gene expression analysis of WNT5A, WNT5B, RSPO1,
DKK1, DKK2, DKK3, SFRP2 and FRZB in hBMSC and relative adipocytes from two healthy donor (#1 and #2). The result values represent the
values of the fold change in RNA expression between the gene of interest and b-actin. The mean values and 95% CI from three independent
experiments done in quadruplicate are shown. ***Po0.001, **Po0.005 and *Po0.05, by two-tailed unpaired Student’s t-tests. (c, d) Western
blot analysis for GSK3β and phospho-GSK3 β in HPDE and HPDE/KRAS cells cultured with conditional medium (CM) from hBMSC (hBMSCCM) or
adipocytes (ADIPOCM) from two healthy donor. γ-Tubulin was used as loading control. The relative protein quantification, using ImageJ
software (https://imagej.nih.gov/ij/), was performed and relative GSK3 and γ-tubulin ratio are indicated.
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obtained using the Illumina Genome Studio software (Genome Studio
V2011.1, San Diego, CA, USA). Raw data were loess normalized with the
Lumi R package (https://bioconductor.org/biocLite.R) and further pro-
cessed with Excel software. Each microarray experiment was repeated
twice. Differentially expressed transcripts were tested for network and
functional interrelatedness using the IPA software program (Ingenuity
Systems, Redwood, CA, USA). Gene expression microarray data have been
deposited in the GEO database with accession number (GSE104536).
Statistical analysis
All results were expressed as the 95% confidence interval for at least three
independent experiments performed in triplicate. All of the statistical
analyses were performed using the GraphPad Prism software program
(version 4.0c; GraphPad Software, La Jolla, CA, USA).
RESULTS
Adipocytes secreted factors induce EMT and aggressiveness in
in vitro models of pancreatic preneoplastic lesions
Initially, we established two adipogenic models from hBMSCs from
healthy donors. hBMSC were grown in culture media able to
induce hBMSC differentiation into mature and functionally active











Figure 3. Adipocytes sustain pancreatic preneoplastic lesions aggressiveness through a WNT paracrine network. (a) Western blot analysis for
Vimentin, β-catenin, phpspoGSK3 and total GSK3 of HPDE and HPDE/KRAS cultured with hBMSCCM or adipocytes (ADIPOCM) treated or untreated
with vantictumab. γ-Tubulin was used as loading control. The relative protein quantification, using ImageJ software, was performed and relative GSK3
and γ-tubulin ratio are indicated. (b) Cell proliferation assay of HPDE and HPDE/KRAS cell lines cultured with the conditional medium from hMBSC
and adipocytes treated or untreated with vantictumab. The mean values and 95% confidence interval (CI) from three independent experiments done
in quadruplicate are shown. (c) Bar histograms of cell migration levels of HPDE and HPDE/KRAS cell lines cultured with the conditioned medium from
hMBSC and adipocytes treated or untreated with vantictumab. The mean values and 95% CI from three independent experiments done in
quadruplicate are shown. ***Po0.001 by two-tailed unpaired Student’s t-tests. Photographs of the wound area were taken by using phase-contrast
microscopy immediately at indicated time point after the incision. All these experiments were performed using hBMSC isolated from the healthy
donor 1 (#1) and its relative adipocytes. (d) Transwelll invasion assay of HPDE and HPDE/KRAS cell lines cultured with the conditioned medium from
adipocytes and hBMSC control cells with or without vantictumab. The invasion chambers were used for treated and untreated group. The values
obtained were calculated by averaging the total number of the cells from three filters. All experiments were performed in triplicate. The mean values
and 95% CI from three independent experiments done in quadruplicate are shown. ***Po 0.001, **Po0.005, *Po0.05 and NS (Not Significative), by
one-way analysis of variance and post Dunnett's mutiple comparison post test using hBMSC as control.
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lipid droplets by light microscopy analysis and Oil Red O staining
(Figure 1a). To further confirm adipocytes differentiation, we
measured a significant increasing expression of ADIPOQ and
leptin genes in hBMSC, pre-adipocytes and fully differentiated
adipocytes (Figure 1b).
To test the hypothesis that factors secreted by adipocytes could
be responsible for EMT and aggressiveness of pancreatic
preneoplastic lesions, we used an in vitro experimental cell
transformation models consisting in the stable expression of
activated KRAS (HPDE/KRAS) in HPDE cell line. These cell lines
were cultured with medium conditioned by hBMSC (hBMSCCM), or
by fully differentiated adipocytes (ADIPOCM). We measured a
significantly higher expression of the mesenchymal marker
vimentin in HPDE and HPDE/KRAS cell lines when cultured with
ADIPOCM if compared with the same cells cultured with hBMSCCM
from two different healthy donors (Figure 1c and Supplementary
Figure 1). We measured significantly higher proliferation rates in
HPDE and HPDE/KRAS cells cultured with ADIPOCM compared with
hBMSCCM (Figure 1d). Moreover, we measured also a significantly
higher migration rate of these cell lines when co-cultured with
Figure 4. Adipocytes-derived WNT secreted factors induced expression and cellular rearrangement of ROR2 in pancreatic preneoplastic
lesions. (a) Western blot analysis for the expression of ROR2 in HPDE and HPDE/KRAS cultured with ADIPOCM and hBMSCCM treated or
untreated with vantictumab. GAPDH was used as loading control. (b) Immunofluorescence colocalization analysis for ROR2 (red) and FZD
(green) receptors in HPDE and HPDE/KRAS cells cultured with ADIPOCM or with hBMSCCM treated or untreated with vantictumab. Fluorescence
intensity analysis was performed by ImageJ software. Fluorescence intensity analysis was performed by ImageJ software and bars represent
mean± s.d. from analysis of four separate high-power field images. ***Po0.001, by two-tailed unpaired Student’s t-test.
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adipocytes cells compared with hBMSC control cells at early time
points when the differences in proliferation were negligible
(Figure 1e). Interestingly, in co-cultured conditions this effect
was more evident for HPDE/KRAS cells with respect to HPDE
control cells (Supplementary Figure S2).
To further confirm that adipose tissue could be responsible for
pancreatic preneoplastic lesions aggressiveness, we established
primary adipocytes culture from the white adipose tissue of a
healthy subject (primary-ADIPO) (Supplementary Figure S3A). To
validate that factors secreted by primary adipocytes could be
responsible for EMT and aggressiveness of pancreatic preneo-
plastic lesions, HPDE and HPDE/KRAS cells were cultured with
conditioned medium from primary-ADIPO (primary-ADIPOCM). We
measured a significantly higher expression of the mesenchymal
marker vimentin in HPDE and HPDE/KRAS cell lines when cultured
with primary-ADIPOCM if compared with the same cells cultured
with control medium (Supplementary Figure S3B). Moreover, we
measured also a significantly higher migration rate of these cell
lines when cultured with primary-ADIPOCM compared with control
medium (Supplementary Figure S3C).
Adipocytes sustain pancreatic preneoplastic lesions
aggressiveness through a WNT paracrine network
In order to identify the factors secreted by adipocytes that could
be responsible for accelerating EMT in the pancreatic preneoplas-
tic models, we compared gene expression profiles and narrowed
our analysis to genes coding for proteins in the extracellular space
that exhibited significantly higher expression in fully differentiated
adipocytes than in their respective in hBMSC from two healthy
donors. We found an overexpression of several genes coding for
soluble modulators of the non-canonical WNT signaling pathway,
including FRZB, SFRP2, RSPO1, WNT5A and 5B. Moreover, we
measured the significant downregulation of genes encoding for
members of the Dickkopf family proteins—DKK1, 3—that are
known to antagonize WNT canonical pathway (Figures 2a and b).
Consistently, we found a higher inhibitory phosphorylation of
GSK3 in HPDE and HPDE/KRAS cells cultured with ADIPOCM
compared with hBMSCCM (Figures 2c and d).
In order to demonstrate that these adipocyte-secreted WNT
factors were indeed responsible for the EMT induced in HPDE
cells, we used vantictumab, a monoclonal antibody directed
against the extracellular portion of WNT receptors (FZDs). In this
regard, we demonstrated a measurable reduction of the expres-
sion of vimentin, β-catenin and phospho-GSK3-β in HPDE and
HPDE/KRAS cells when cultured with ADIPOCM and treated with
vantictumab if compared with the same cells cultured with
ADIPOCM and treated with a control mAb, at levels similar with
those measured in the same cells cultured with hBMSCCM
(Figure 3a). Consistently, we measured a significant reduction in
the proliferation (Figure 3b), migration (Figure 3c) and invasion
rates (Figure 3d) of HPDE and HPDE/KRAS cells when cultured with
ADIPOCM and treated with vantictumab if compared with the
same cells cultured with ADIPOCM and treated with mAb control.
This effect was not observed in cells cultured with hBMSCCM
(Figures 3b-d).
Collectively, these results provide strong evidences supporting
a model in which the induction of an EMT phenotype in
pancreatic premalignant lesions by adipocytes involve the binding
of WNT proteins to the FZDs receptors.
ROR2 nuclear shuttling mediates pancreatic preneoplastic lesions
aggressiveness induced by adipocytes-derived WNT paracrine
factors
Ror2 is a Frizzled family protein, which belongs to the 7 trans-
membrane class of receptors. Ror2 interact with several of the Wnt
ligands to activate a combination of non-canonical and canonical Wnt
signaling activity. In particular, WNT5A induced the formation of a
complex between ROR2 and Frizzled, resulting in Ser/Thr phosphor-
ylation of Ror2 and the recruitment of Dvl, Axin and GSK3β.27 We
measured a significantly higher expression of ROR2 in HPDE and
HPDE/KRAS cell lines when cultured with ADIPOCM if compared with
the same cells cultured with hBMSCCM. Immunofluorescence analysis
showed colocalization of FZD receptors and ROR2 in these cells.
Treatment with vantictumab was able to modulate ROR2 expression
and to interfere with binding of FZD with ROR2, triggering to ROR2
cellular rearrangement (Figures 4a and b).
Since recent evidences have been provided for the nuclear
translocation of the other member of the ROR family, ROR1,28 we
performed a bioinformatics analysis on the potential nuclear
translocation of ROR2. Based on nuclear translocation sequences
(NLS)-mapper software (http://nls-mapper.iab.keio.ac.jp/), we iden-
tified several NLSs that have good potential for ROR2 nuclear
localization (Table 1). In this regard, we performed a western
blotting and immunofluorescence analyses of ROR2 in the
different cellular compartments, and we demonstrated that
ADIPOCM induced not only a ROR2 overexpression but also the
nuclear translocation of its 50 kDa short isoform. Treatment with
vantictumab was able to modulate ROR2 expression and to
interfere with its nuclear localization (Figures 5a and b).
These results suggest that the WNT paracrine factors secreted
by adipocytes could sustain cell proliferation and invasion in
pancreatic premalignant lesions by inducing the nuclear shuttling
of ROR2.
DISCUSSION
In this study, we demonstrated that adipocytes could induce EMT
and aggressiveness in models of pancreatic preneoplastic lesions
by orchestrating a complex paracrine signaling of soluble
modulators of the non-canonical WNT signaling pathway that
Table 1. Summary of the score for the nuclear localization of ROR2 by NLS-mapper software
Predicted bipartite NLS
Start position Sequence AA length Score
242 RSRTPKPRELCRDECEVLESDLCRQEYTIAR 31 4
438 TPQRRQLMASPSQDMEMPLINQHKQAKLK 29 5.9
438 TPQRRQLMASPSQDMEMPLINQHKQAKLKEI 31 4.3
461 KQAKLKEISLSAVRFMEELGEDRFGKVYKG 30 7
465 LKEISLSAVRFMEELGEDRFGKVYKG 26 4.9
481 EDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK 32 4.4
Nuclear localization of ROR2. Higher scores indicate stronger NLS activities: Score of 8, 9 or 10 is exclusively localized to the nucleus; Score of 7 or 8 partially
localized to the nucleus; Score of 3, 4 or 5 localized to both the nucleus and the cytoplasm; Score of 1 or 2 localized to the cytoplasm. Abbreviations: NLS,
nuclear translocation sequence; ROR2, receptor tyrosine kinase-like orphan receptor 2.
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determine, in turn, the activation and nuclear translocation
of ROR2.
The most compelling preclinical evidences about the link
between obesity and pancreatic carcinogenesis indicated that a
high-fat, high-calorie diet could accelerates early pancreatic
neoplasia in the conditional K-Ras G12D mouse model.29 More
recently, a complex cross-talk between adipocytes, tumor-
associated neutrophils and pancreatic stellate cells has been
described to promote desmoplasia, accelerate tumor growth and
impair delivery/efficacy of chemotherapeutics, with interleukin-1β
secreted by all these cells having a major role in this
cooperation.30
Our study contributes to this field by providing evidence,
through an inductive approach, of a role for several modulators of
the non-canonical WNT signaling as the paracrine network
between adipocytes and induction of EMT in preneoplastic
pancreatic lesions. The anti-WNT receptors monoclonal antibody
vantictumab was able to modulate these effects. Interestingly,
EMT was established as one of the pharmacodynamic biomarker
in surrogate tissues and tumor tissues from serial biopsies in the
first-in-human Phase 1a study for vantictumab in patients with
advanced solid tumors.31
ROR2 is a tyrosine kinase receptor with a well-established role in
the activation of non-canonical WNT signaling pathways. Recent
evidences showed that ROR2 was highly expressed in a number of
different tumors,27 including pancreatic cancer,32 and could serve
as a potential target for drug development. Depending on
receptor context, WNT proteins are either able to activate the
non-canonical pathway,33 and to antagonize the canonical path-
way by promoting the activation of ROR1 and 2.34 In case of
Figure 5. ROR2 nuclear shuttling mediates pancreatic preneoplastic lesions aggressiveness induced by adipocytes-derived WNT paracrine
factors. (a) Western blot analysis for the expression of both 105 and 50 kDA protein isoforms of ROR2 in cytosolic and nuclear compartment
from HPDE and HPDE/KRAS cultured with ADIPOCM and hBMSCCM treated or untreated with vantictumab. GAPDH and Histone H3 were used
as loading and cellular fraction compartment controls. (b) Immunofluorescence colocalization analysis for ROR2 (green) and nucleus (blue) in
HPDE and HPDE/KRAS cells cultured with ADIPOCM or with hBMSCCM treated or untreated with vantictumab. Fluorescence intensity analysis
was performed by ImageJ software.
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activation of the canonical WNT signaling, ROR2 expression is lost,
supporting its role as a gatekeeper for the canonical pathway.
Alternatively, in tumors driven by non-canonical WNT signaling,
ROR2 expression is commonly increased and could have a critical
role in driving tumorigenesis.32 In this regard, ROR2 specifically
interacts only with non-canonical WNT5A35 by establishing a
ligand/receptor complex including ROR2-WNT5A-FZD35,33 In our
present study, we demonstrated that WNT factors secreted by
adipocytes could enhance the aggressiveness of pancreatic
preneoplastic lesions through a mechanism that require the
interaction of ROR2-WNT-FZD. Vantictumab reduced ROR2–FZD
interaction and inhibited proliferation, migration and invasion
rates of pancreatic preneoplastic lesions. Most importantly, we
demonstrated for the first time the nuclear translocation of ROR2,
and that vantictumab was able to inhibits its shuttling. Interest-
ingly, tumor-derived WNT5A has also been recently indicated as
responsible for a dedifferentiation process of adipocytes repro-
gramming toward a fibroblast-like phenotype in a model of co-
culture with MiaPaCa2 pancreatic cancer and 3T3-L1 cells.36
Further investigations of this potential bidirectional cross-talk in
more complex in vivo models are warranted.
This study, however, had some limitations. The effort to develop
appropriate in vitro models that could closely recapitulate the
cross-talk between human epithelial cells and normal adipocyte is
hampered by the difficulty to directly culture and expand fully
mature adipocytes. Moreover, different cell lines commonly used
in the study of adipocyte biology could either derive from murine
fibroblasts (3T3-L1 cells),37 or be developed from human
metastatic liposarcoma (LS14 cells).38 In our study, we used two
primary human adipogenic models in which bone marrow stromal
cells from healthy donors were able to differentiate into mature
and functionally active adipocytes. These models allowed a
comparison between adipocytes and their respective undiffer-
entiated counterparts, the only strategy to directly identify the
actual secreted factors responsible for EMT induction and, in turn,
a more aggressive phenotype in models of pancreatic preneo-
plastic lesions, an analysis that would be otherwise impossible by
using only mature adipocytes. Moreover, we corroborated the
clinical relevance of our findings by demonstrating that a similar
induction of EMT in HPDE cells could be obtained also with
conditioned medium from fully differentiated human primary
adipocytes.
In conclusion, our present study demonstrated that a non-
canonical WNT paracrine network secreted by adipocytes is
responsible for EMT induction and, in turn, a more aggressive
phenotype in models of pancreatic preneoplastic lesions, repre-
senting the molecular mechanisms linking obesity with pancreatic
cancer progression. This signaling pathway could represent a
novel target for pancreatic cancer chemoprevention. Most
importantly, these factors could serve as novel biomarkers to
select a risk population among obese subjects for screening and,
thus, early diagnosis of pancreatic cancer.
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